The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new ...

The US Food and Drug Administration will now require Covid-19 vaccines to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The commission to "Make America Healthy Again" was tasked with investigating chronic illness and delivering a plan to fight childhood diseases.

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

"The trust issues are quite far-reaching" and impact public perception towards health-based changes across the U.S., a health professor told Newsweek.